The Borges Lab is focused on the development of novel vaccines and combination immunotherapy for breast cancer and also on potential biologic differences and therapeutic targets for young women's’ breast cancer.
The Diamond laboratory is focused on the development of novel targeted therapies for triple-negative breast cancer, specifically cell cycle targeting agents and combination immunotherapy.
The Kabos lab translates preclinical findings into novel treatments for patients with breast cancer. The Kabos lab focuses on the role of breast cancer stem cells and tumor microenvironment in treatment resistance.
The Lyons laboratory focuses on mechanisms of semaphorin 7a and lymphatic mediated metastasis of breast cancer. The results of these translational studies have potential to instruct therapy aimed at prevention of breast cancer metastasis.